Literature DB >> 10717535

In vivo interactions of rabbit enteropathogenic Escherichia coli O103 with its host: an electron microscopic and histopathologic study.

U Heczko1, A Abe, B B Finlay.   

Abstract

A family of human and animal pathogens, including enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC), trigger formation of 'attaching and effacing' lesions on cultured and intestinal epithelial surfaces. However, our understanding of these events in vivo is incomplete. To further study these interactions in a natural infection model, weaned rabbits were infected with rabbit enteropathogenic E. coli O103 (REPEC O103), followed clinically, and infected tissues were evaluated by electron and light microscopy. Of the 36 rabbits challenged, morbidity and mortality were 65 and 23%, respectively. Twenty-four hours after infection, expression of fimbriae-like organelles was observed on the bacterial surface. Microvilli of ileal Peyer's patches (PP) became disorganized, and intestinal mucus secretion increased which coincided with intraluminal binding of the pathogen in the proximal colon. Forty-eight hours after infection, there was conspicuous lack of fimbriae-like organelle expression, while bacterial adherence preferentially occurred at the domed villi of PP. Seventy-two hours after infection, broad morphological heterogeneity was noted within pedestals beneath attached bacteria, including extended pseudopods. We conclude that REPEC O103 express surface organelles during initial exposure to the host, that the initial target sites of adherence are the domed villi of ileal PP, and that increased mucus secretion occurs during REPEC O103 infection. As well, extended pseudopod formation was demonstrated in vivo.

Entities:  

Mesh:

Year:  2000        PMID: 10717535     DOI: 10.1016/s1286-4579(00)00291-4

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  8 in total

1.  Role of EspA and intimin in expression of proinflammatory cytokines from enterocytes and lymphocytes by rabbit enteropathogenic Escherichia coli-infected rabbits.

Authors:  Karina Ramirez; Rocio Huerta; Eric Oswald; Carlos Garcia-Tovar; Jose Manuel Hernandez; Fernando Navarro-Garcia
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Decreased apoptosis in the ileum and ileal Peyer's patches: a feature after infection with rabbit enteropathogenic Escherichia coli O103.

Authors:  U Heczko; C M Carthy; B A O'Brien; B B Finlay
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 3.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

4.  Biosecurity practices and causes of enteritis on Ontario meat rabbit farms.

Authors:  Jennifer Kylie; Marina Brash; Ashley Whiteman; Brian Tapscott; Durda Slavic; J Scott Weese; Patricia V Turner
Journal:  Can Vet J       Date:  2017-06       Impact factor: 1.008

5.  Enteropathogenic Escherichia coli prevalence in laboratory rabbits.

Authors:  Alton G Swennes; Ellen M Buckley; Carolyn M Madden; Charles P Byrd; Rachel S Donocoff; Loretta Rodriguez; Nicola M A Parry; James G Fox
Journal:  Vet Microbiol       Date:  2013-01-23       Impact factor: 3.293

6.  Enzootic enteropathogenic Escherichia coli infection in laboratory rabbits.

Authors:  Alton G Swennes; Ellen M Buckley; Nicola M A Parry; Carolyn M Madden; Alexis García; Peter B Morgan; Keith M Astrofsky; James G Fox
Journal:  J Clin Microbiol       Date:  2012-05-09       Impact factor: 5.948

7.  Maternal milk contains antimicrobial factors that protect young rabbits from enteropathogenic Escherichia coli infection.

Authors:  Mélanie Gallois; Thierry Gidenne; Christian Tasca; Cécile Caubet; Cécile Coudert; Alain Milon; Séverine Boullier
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

Review 8.  Attaching-effacing bacteria in animals.

Authors:  A D Wales; M J Woodward; G R Pearson
Journal:  J Comp Pathol       Date:  2005-01       Impact factor: 1.311

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.